Advertisement

Topics

Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance

06:30 EST 23 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Fourth Quarter Revenues of $513.9 million, up 6.1% Versus Prior Year Period; up 6.9% on Constant Currency Basis Fourth Quarter GAAP Diluted EPS of $1.29, down 31.4% Versus Prior Year Period Fourth Quarte...

Other Sources for this Article

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President of Investor Relations
610-948-2836

NEXT ARTICLE

More From BioPortfolio on "Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...